Kuljanin Jadranka, Janković Ivana, Nedeljković Jovan, Prstojević Dusica, Marinković Valentina
Laboratory for Radiation Chemistry and Physics, Vinca Institute of Nuclear Sciences, Belgrade, Yugoslavia.
J Pharm Biomed Anal. 2002 Jun 15;28(6):1215-20. doi: 10.1016/s0731-7085(02)00021-3.
The formation of the complex between alendronate, non-chromophoric bisphosphonate drug important for the treatment of a variety of bone diseases, and iron(III) chloride in perchloric acid solution was studied. The stoichiometric ratio of alendronate to Fe(III) ions in the chromophoric complex was determined to be 1:1. The conditional stability constant was logK'(ave)=4.50(SD=0.15), indicating that the Fe(III)-alendronate complex is a complex of medium stability. The optimum conditions for this reaction were ascertained and a spectrophotometric method was developed for the determination of alendronate in the concentration range 8.1-162.5 microg ml(-1), the detection limit being 2 microg ml(-1). The method was validated for the direct determination of alendronate in tablet dosage formulations.
研究了阿仑膦酸钠(一种对多种骨疾病治疗很重要的非发色双膦酸盐药物)与高氯酸溶液中的氯化铁(III)形成络合物的情况。测定了发色络合物中阿仑膦酸钠与铁(III)离子的化学计量比为1:1。条件稳定常数为logK'(ave)=4.50(标准差=0.15),表明铁(III)-阿仑膦酸钠络合物是一种中等稳定性的络合物。确定了该反应的最佳条件,并建立了一种分光光度法,用于测定浓度范围为8.1 - 162.5微克/毫升的阿仑膦酸钠,检测限为2微克/毫升。该方法经验证可直接测定片剂剂型中的阿仑膦酸钠。